ArticleJournal of experimental & clinical cancer research : CR2021

Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation.

Balawant Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.